Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses

Neoplasia

Volumn 7, Issue 8, 2005, Pages 723-729

  Jiang, Hong ^a   Alemany, Ramon ^b   Gomez Manzano, Candelaria ^a   Medrano, Diana R ^a   Lemoine, Michael G ^a   Olson, Melissa V ^a   Alonso, Marta M ^a   Lee, Ok Hee ^a   Conrad, Charles C ^a   Yung, W K Alfred ^a   Fueyo, Juan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Adenovirus; CR1; E1A; Glioma; Oncolytic

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; CR2 RECEPTOR; E1A PROTEIN; LYMPHOCYTE ANTIGEN; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG; LUCIFERASE;

ADENOVIRUS; ARTICLE; ASTROCYTE; CELL CYCLE S PHASE; CELL PROLIFERATION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION; BRAIN TUMOR; CELL SURVIVAL; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN ADENOVIRUS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; ASTROCYTES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, VIRAL; GLIOMA; HUMANS; LUCIFERASES; MUTATION; VIRUS REPLICATION;

EID: 33644691028     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.04793     Document Type: Article

References (24)

1. Chiocca EA (2002). Oncolytic viruses. Nat Rev Cancer 2, 938-950.
2. Jiang H, Conrad C, Fueyo J, Gomez-Manzano C, and Liu TJ (2003). Oncolytic adenoviruses for malignant glioma therapy. Front Biosci 8, d577-58.
3. Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK, and Kyritsis AP (2000). A mutant oncolytic adenovirus targeting the Rb pathway produces antiglioma effect in vivo. Oncogene 19, 2-12.
4. Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, et al. (2003). Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst 95, 652-660.
5. Frisch SM and Mymryk JS (2002). Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3, 441-452.
6. Avvakumov N, Wheeler R, D'Halluin JC, and Mymryk JS (2002). Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses. J Virol 76, 7968-7975.
7. Shenk T (1996). Adenoviridae: the viruses and their replication. In Fields BN, Knipe DM, Howley PM (Eds.), Virology, pp. 2111-2148. Lippincott-Raven Publishers, Philadelphia, PA.
8. Graham FL and Prevec L (1991). Manipulation of adenovirus vectors. Methods Mol Biol 7, 109-128.
9. Jones N and Shenk T (1978). Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13, 181-188.
10. Gomez-Manzano, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, et al. (2004). A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene 23, 1821-1828.
11. Johnson DG, Ohtani K, and Nevins JR (1994). Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8, 1514-1525.
12. Egan C, Jelsma TN, Howe JA, Bayley ST, Ferguson B, and Branton PE (1988). Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol Cell Biol 8, 3955-3959.
13. Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA, and Kyritsis AP (1996). Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 12, 103-110.
14. Fattaey AR, Harlow E, and Helin K (1993). Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 13, 7267-7277.
15. Ikeda MA and Nevins JR (1993). Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol 13, 7029-7035.
16. Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS, and Gallimore PH (2000). Regulation of the 26S proteasome by adenovirus E1A. EMBO J 19, 4759-4773.
17. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, et al. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376.
18. Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, Williams A, Hawkins L, and Kim D (2000). An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med 6, 1134-1139.
19. Whyte P, Ruley HE, and Harlow E (1988). Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol 62, 257-265.
20. Whyte P, Williamson NM, and Harlow E (1989). Cellular targets for transformation by the adenovirus E1A proteins. Cell 56, 67-75.
21. Lee BH, Liu M, and Mathews MB (1998). Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107. J Virol 72, 1138-1145.
22. Mymryk JS and Bayley ST (1993). Induction of gene expression by exon 2 of the major E1A proteins of adenovirus type 5. J Virol 67, 6922-6928.
23. Balague C, Noya F, Alemany R, Chow LT, and Curiel DT (2001). Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes. J Virol 75, 7602-7611.
24. Yoshida K, Higashino F, and Fujinaga K (1995). Transcriptional regulation of the adenovirus E1A gene. Curr Top Microbiol Immunol 199, 113-130.